Other incretin projects : Lilly acquired Protomer Technologies in late 2024 specifically to get access to novel glucagon/GLP-1 peptides and oral incretins
Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L
On an episode of the Women Want Strong Men podcast, we covered the ins and outs of navigating weight loss medications with Anna Griffith, DNP
These symptoms may indicate accelerated muscle loss requiring prompt intervention
These same studies also found improvements in mitochondrial function, metabolic markers, and reductions in oxidative stress and inflammation
As a trusted medical weight loss center in Southlake, MyFitMed is committed to helping patients achieve healthier outcomes through customized treatment plans and professional guidance